BRAIN and WeissBioTech join forces
Strategic investment of BRAIN in enzyme production, distribution and marketing
BRAIN and WeissBioTech GmbH have formed a strategic partnership in the rapidly growing industrial enzyme sector. Through this strategic move BRAIN has obtained direct access to the lucrative industrial enzyme market. Together with its partner WeissBioTech, BRAIN now established a growing international company network with worldwide access to an extensive range of enzymes and producer strains, as well as the associated technologies required for identification, development and production of products based on enzymes and biocatalysts for consumers and business partners.
The strategic investment of BRAIN into WeissBioTech was made to get access to an established and lucrative enzyme business and also, in order to strengthen the position of WeissBioTech in the enzyme market in future business. The further details of the transaction have not been disclosed.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.